Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 01/19/16 → 03/30/18 |
Funding
- PPD Development LP: $7,150.00
Pfizer: A Phase IV Trial to Assess the Effectiveness of Apixaban Compared with Usual Care Anticoagulation in Subjects with Non-Valvular Atrial Fibrillation Undergoin Cardioversion
- Rashba, Eric (PI)
- Almasry, Ibrahim (CoPI)
- Fan, Roger (CoPI)
Project: Research